Ụlọ Ọrụ Na-ahụ Maka N'Ịntanet, Canada Nweta Ụlọ, European Delivery Delivery

Ngwaọrụ (811803-05-1)

Rating:
5.00 si 5 dabere na 1 ahịa fim
SKU: 811803-05-1. Category:

AASraw nwere ikikere na mmepụta ikike site na gram ka usoro nchịkọta nke Apatinib (CAS 811803-05-1), n'okpuru usoro CGMP na usoro nchịkọta mma.

Abatinib, obere omekota omekorita tyrosine kinase nke na-egbochi uto uto endothelial nke na-eme ka onye nata-2, kwadoro maka adenocarcinoma gastric metastatic na China na Oct 2014. Nke a bụ akụkọ mbụ banyere iji ya maka ọrịa cancer dị elu dịka ụdị usoro ọgwụgwọ nke atọ ruo ugbu a.

AASRAW ntụ ntụ PDF Icon

Product Description

Video ngwa


Akpado aha njirimara

aha: Abatinib
CAS: 811803-05-1
Molekụla Formula: C24H23N5O
Ọbara arọ: 397.47232
Melt Point: 111-114 ° C
Nchekwa Nche: -20 ° C
agba: Yellow Yellow to edozi


Apatinib (811803-05-1) iji mee ihe na steroid steroid

aha

Apatinib (CAS 811803-05-1), makwaara dị ka YN968D1, Mesylate.

Ịmepụta Ịntanetị

A na-edozi ndị ọrịa cancer ọtụtụ doses nke Apatinib kwa ụbọchị maka ụbọchị 28. A kwadoro Apatinib na doses n'okpuru 750 mg / ụbọchị, 3 nke 3 dose na-amachide ọgwụ ndị na-egbu egbu na 1000 mg / ụbọchị, a kwadokwara ọgwụ kachasị elu ka be850 mg / ụbọchị.

Ịdọ aka ná ntị na Apatinib

Ị ghaghị ịma mmetụta dị iche iche mgbe ị na-ewere Apatinib. Ejiri ọbara mgbatị na ụkwụ ụkwụ na-ahụkarị akụkụ ahụ na-emekarị; Otú ọ dị, ọnyá nke apatinib bụ ihe a na-apụghị ịchịkwa ma na-ekwe omume.

Ntuziaka ọzọ

Rivoceranib (Apatinib, YN968D1) bụ LSK BioPharma, bụ onye na-agwọ ọgwụ na-emepụtaghị ọgwụ na-abụghị nke China, maka ọgwụgwọ nke ọrịa ara ehi na-arịa ọrịa cancer, ma ọ bụ ọrịa cancer metastatic, cancer cancer, na carcinoma hepatocellular. A na-edezi YN968D1 na patented na Advenchen Laboratories na Southern California. A na-ere ahịa ugbu a na Apatinib na China maka ọrịa cancer gastric dị ukwuu site n'aka onye na-ede akwụkwọ ikike na Chinese, Jiangsu Hengrui MedicineCo., Ltd n'okpuru aha Aitan®. LSK BioPharma nwere ikike zuru ụwa ọnụ (ewepụghị China) ma kwadoro maka mmepe na ahịa nke rivoceranibin South Korea.

Rivoceranib bụ onye nwere ike ịmepụta ihe na-eme ka ọ bụrụ onye na-anabata ihe na-akpata 2 (nke a maara dịka VEGFR2) bụ nke na-akwado ụzọ ụzọ mbụ maka tumor-mediatedangiogenesis. A na-anwale ya n'ihe gbasara ọrịa 1,000 n'ụwa nile ma gosipụta nrụpụta ọrụ na ọtụtụ ọrịa cancer gụnyere cancer cancer, cancer cancer colorectal, carcinoma hepatocellular, ọrịa cancer na-abụghị obere cell, ọrịa cancer esophageal, thyroidcancer, mesothelioma, na etuto neuroendocrin. O gosipụtakwa na ọ ga - eme ka ihe dị mma na - emepụta ya na chemotherapeutics na immunotherapy, nakwa maka ọgwụgwọ.


Esi zuta Apatinib site na AASraw

1.To kpọtụrụ anyị site na email anyị usoro nyocha, ma ọ bụ skypeonye na-ahụ maka ndị ahịa (CSR).
2.To nye anyị ọnụọgụgụ na adreesị gị.
3.OUR CSR ga-enye gị nkọwa, okwu nkwụ ụgwọ, nọmba nchịkọta, ụzọ nnyefe na ụbọchị mbata echere (ETA).
4.Bayment done and the goods will be sent out na 12 awa (N'ihi na iwu n'ime 10kg).
5.Goods natara ma kwuo ihe.


=

COA

HNMR

Ezi ntụziaka

Ntughari & akwukwo akwukwo

1 nyochaa maka Ngwaọrụ (811803-05-1)

  1. gosiri 5 si 5

    Aasraw -

    Apatinib powder is genius

Tinye a nyochaa

Na adreesị email gị agaghị bipụtara. Chọrọ ubi na- *